KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 0.32%.

  • Biolife Solutions' EBIT Margin rose 16400.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.03%, marking a year-over-year decrease of 317800.0%. This contributed to the annual value of 8.67% for FY2024, which is 222300.0% up from last year.
  • As of Q3 2025, Biolife Solutions' EBIT Margin stood at 0.32%, which was up 16400.0% from 65.47% recorded in Q2 2025.
  • Biolife Solutions' EBIT Margin's 5-year high stood at 0.32% during Q3 2025, with a 5-year trough of 218.96% in Q4 2022.
  • Moreover, its 5-year median value for EBIT Margin was 28.81% (2022), whereas its average is 52.12%.
  • In the last 5 years, Biolife Solutions' EBIT Margin plummeted by -1742900bps in 2022 and then skyrocketed by 1747600bps in 2024.
  • Biolife Solutions' EBIT Margin (Quarter) stood at 49.5% in 2021, then tumbled by -342bps to 218.96% in 2022, then rose by 16bps to 184.05% in 2023, then soared by 95bps to 9.29% in 2024, then surged by 97bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 65.47% for Q2 2025, and 5.09% during Q1 2025.